SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-012183
Filing Date
2023-11-07
Accepted
2023-11-07 13:37:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27650
2 filename2.txt TEXT-EXTRACT 1507
  Complete submission text file 0000000000-23-012183.txt   40457
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filed for) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)